Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta‐analysis

15 Oct 2021

Abstract excerpt

OBJECTIVE: To investigate O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis by pooling relevant open published data. METHODS: Clinical studies relevant to MGMT gene promoter methylation and lung cancer were systematic electronic searched in the databases of Medline, EMBASE, Ovid, Web of Science, and CNKI. Data of true positive (tp),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Glioma Diagnosis and Treatment
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34651448
DOI: 10.1111/1759-7714.14186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta‐analysisPMID 34651448Read ↗

O-6-methylguanine-DNA methyltransferase gene promoter methylation and lung cancer risk: A meta-analysis.Semantic proximity Read ↗

P16INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysisSemantic proximity Read ↗

Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung CancerSemantic proximity Read ↗

Exploring the Efficacy and Feasibility of using Biomarkers for Early Screening of Lung Cancer and their Potential Reverberation on Mortality Rate: A ReviewSemantic proximity Read ↗

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateSemantic proximity Read ↗

DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNASemantic proximity Read ↗

Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging featuresSemantic proximity Read ↗

DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancerSemantic proximity Read ↗

Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaSemantic proximity Read ↗

A Panel of DNA Methylation Biomarkers for Detection and Improving Diagnostic Efficiency of Lung CancerSemantic proximity Read ↗

An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNASemantic proximity Read ↗

Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta‐analysis updateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.